Amoeba SA
Amoeba SA has a negative equity position of EUR -5.36 million and a debt-to-equity ratio of -2.28, indicating a leveraged capital structure with liabilities exceeding assets. The company's liquidity position is assessed as medium, with a current ratio of 0.98, suggesting limited short-term liquidity cushion. Operating cash flow of EUR -6.09 million and free cash flow of EUR -8.43 million indicate negative cash generation from operations. Profitability metrics show significant underperformance relative to industry norms. Return on equity of 154.86% is positive but driven by negative equity rather than earnings, while return on assets of -8.19% indicates asset underutilization. The company reported EUR -6.78 million operating income and EUR -8.30 million net income, with gross profit of EUR -631,280, reflecting operational losses. The company's revenue concentration is not disclosed in available segments, but its business model focuses on water treatment solutions for industrial and commercial clients. No specific geographic revenue breakdown is provided in the input data. Growth trajectory analysis is constrained by the absence of historical revenue data. The company reported EUR 0 revenue in the latest period, suggesting operational challenges or reporting anomalies. Analysts have assigned a mean price target of EUR 1.47 with mixed recommendations (2 strong buys, 1 hold). Key risk factors include negative net cash position after debt subtraction and significant operating losses. Dilution risk is assessed as low, with no near-term pressure indicated in the input data. No recent filings or transcripts are provided to assess material events.
Business. Amoeba SA develops, manufactures, and markets biological products for water treatment, including Cleantech biological solutions and amoebic and Legionella tests.
Classification. Amoeba SA is classified in the Basic Materials economic sector, Chemicals business sector, and Agricultural Chemicals industry with 92% confidence.
- Amoeba SA operates at a significant loss with negative equity and cash flow, indicating severe financial distress.
- The company's debt-to-equity ratio of -2.28 suggests a highly leveraged capital structure with liabilities exceeding assets.
- Return on equity of 154.86% is mathematically positive but driven by negative equity rather than profitability.
- Analysts have assigned a mean price target of EUR 1.47 with mixed recommendations, reflecting uncertainty about the company's value proposition.
- The company's water treatment solutions represent a niche market opportunity but face significant operational and financial challenges.
- # RATIONALES
- {
- "margin_outlook_rationale": "Operating margin is expected to remain negative due to persistent operating losses and lack of revenue visibility.",
- Net cash is negative after subtracting total debt.